Following the seizure of ₹4.91 crore worth of counterfeit medicines from a Bidadi farmhouse, Karnataka Health Minister U.T. Khader has proposed an SIT to investigate a suspected inter-state syndicate involving Himachal Pradesh and Telangana.

  • Medicines worth ₹4.91 crore were seized from an unlicensed repacking facility near Bidadi.
  • The racket allegedly sources cheap drugs from Himachal Pradesh and Telangana.
  • Health Minister U.T. Khader proposed an SIT comprising police and FSDA officials.
  • Counterfeit drugs were being relabeled with major brand names to deceive hospitals.

In a major crackdown on pharmaceutical fraud, Karnataka Health Minister U.T. Khader has proposed the formation of a Special Investigation Team (SIT) to unravel a sophisticated inter-state network involved in the distribution of spurious medicines. The move follows a massive raid on an unlicensed repacking unit located at a farmhouse near Bidadi, where authorities seized medicines valued at ₹4.91 crore.

Preliminary investigations suggest that the syndicate operates across state lines, sourcing low-cost medicines from Himachal Pradesh, Telangana, and other states. These drugs were reportedly brought to Karnataka, relabeled with the names of reputable pharmaceutical brands, and then distributed to hospitals and pharmacies at prices nearly 50% lower than the standard market rate.

Read Also:Taunting Wife for Childlessness is Reprehensible but Not Criminal Cruelty: Allahabad High Court

Why This Matters

BozokMedia analysis shows that the implications of this racket extend far beyond financial fraud; it is a direct assault on public safety. The most alarming aspect of this discovery is that some of the seized counterfeit drugs were intended for use in Intensive Care Units (ICUs). This raises the terrifying possibility that critically ill patients may have already been administered ineffective or harmful substances.

The scale of this operation suggests a deeply entrenched criminal network that prioritizes profit over human lives.

The proposed SIT will consist of two police officers and two officials from the Food Safety and Drug Administration (FSDA). The team's mandate will be to trace the entire supply chain, identify the manufacturers and middlemen, and follow the financial trail to uncover the masterminds. Furthermore, investigators will scrutinize the role of pharmacies and hospitals that received these products to determine if they were complicit or victims of the scam.

Historical Background

The issue of spurious drugs has long been a challenge for Indian regulatory bodies. Criminal syndicates often exploit the gaps in inter-state logistics to move substandard products across borders. In this specific instance, the farmhouse in Kurubarakeranahalli was owned by an individual named Siddaiah and leased to a Dubai-based operator named Prashanth. Local operations were allegedly managed by his relative, Tejas, while an individual named Prabhudeva has already been taken into custody.

Did You Know?: Counterfeit medicines often look identical to genuine ones, making them nearly impossible for even trained medical professionals to detect without laboratory testing.

Frequently Asked Questions

1. What is the scope of the SIT investigation?
The SIT will investigate the manufacturers, transporters, middlemen, and the end-points (hospitals/pharmacies) involved in the inter-state drug supply chain.

2. How were the fake medicines being sold?
They were being relabeled with famous brand names and sold to hospitals at nearly 50% below the market price to ensure quick turnover.